taxonomy (1)
protein (1)
source (1)
structure (0)
composition (16)
disease (0)
reference (1)
site (7)
peptide (9)
- Mus musculus (House mouse)
Taxonomy
- Brain (UBERON_0000955)
Source
Reported structure
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:4 HexNAc:2 (avg mass : 1072.9749 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
Composition
Disease
- Contactin-associated protein-like 2 / Mus musculus
Reported glycosite
-
- Hex:3 HexNAc:2 / N-Linked (avg mass : 910.8325)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- SINLTLDR (8aa)
- VGVHINNTQTK (11aa)
-
- Hex:4 HexNAc:2 / N-Linked (avg mass : 1072.9749)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- SINLTLDR (8aa)
- VGVHINNTQTK (11aa)
- NMANGQPHSVNITR (14aa)
-
- Hex:3 HexNAc:3 / N-Linked (avg mass : 1114.0275)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- VGVHINNTQTK (11aa)
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- SINLTLDR (8aa)
- VGVHINNTQTK (11aa)
- KPGSFANVTIDMCAIIDR (18aa)
- VYCNMTEDKVWTIVSHDLQMQTTVVGYNPEK (31aa)
- NCTDPK (6aa)
- CACGIERNCTDPK (13aa)
- NMANGQPHSVNITR (14aa)
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- GCMESINYNGVNITDLAR (18aa)
- VGVHINNTQTK (11aa)
- KPGSFANVTIDMCAIIDR (18aa)
- NMANGQPHSVNITRHER (17aa)
- NMANGQPHSVNITR (14aa)
-
- Hex:4 HexNAc:3 dHex:1 / N-Linked (avg mass : 1422.3129)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- VGVHINNTQTK (11aa)
-
- Hex:5 HexNAc:3 / N-Linked (avg mass : 1438.3123)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- VGVHINNTQTK (11aa)
-
- Hex:3 HexNAc:5 / N-Linked (avg mass : 1520.4175)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- VGVHINNTQTK (11aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- SINLTLDR (8aa)
- GCMESINYNGVNITDLAR (18aa)
- VGVHINNTQTK (11aa)
- KPGSFANVTIDMCAIIDR (18aa)
- NMANGQPHSVNITR (14aa)
-
- Hex:5 HexNAc:3 dHex:1 / N-Linked (avg mass : 1584.4553)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- CACGIERNCTDPK (13aa)
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- VGVHINNTQTK (11aa)
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- GCMESINYNGVNITDLAR (18aa)
- VGVHINNTQTK (11aa)
- NMANGQPHSVNITRHER (17aa)
- NMANGQPHSVNITR (14aa)
-
- Hex:6 HexNAc:3 dHex:1 / N-Linked (avg mass : 1746.5977)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- VGVHINNTQTK (11aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- CACGIERNCTDPK (13aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- NMANGQPHSVNITR (14aa)
-
- Hex:6 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1891.7126)
- Brain (UBERON_0000955)
- Contactin-associated protein-like 2 / Mus musculus
- VGVHINNTQTK (11aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
